Involvement of the p38 MAPK-NF-κB signal transduction pathway and COX-2 in the pathobiology of meniscus degeneration in humans

Molecular Medicine

Volumn 14, Issue 3-4, 2008, Pages 160-166

  Papachristou, Dionysios J ^a   Papadakou, Eugenia ^b   Basdra, Efthimia K ^c   Baltopoulos, Panagiotis ^d   Panagiotopoulos, Elias ^e   Papavassiliou, Athanasios G ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b KAT HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; P65 PROTEIN; PROTEIN P50; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNEE MENISCUS RUPTURE; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; CYCLOOXYGENASE 2; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MENISCI, TIBIAL; MIDDLE AGED; NF-KAPPA B; OSTEOARTHRITIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 41649114143     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00138.Papachristou     Document Type: Article

References (35)

1. Proctor CS, Schmidt MB, Whipple RR, Kelly MA, Mow VC. (1989) Material properties of the normal medial meniscus. J. Orthop. Res. 7:771-82.
2. McDevitt CA, Webber RJ. (1990) The ultrastructure and biochemistry of meniscal cartilage. Clin. Orthop. Rel. Res. 252:8-18.
3. Ghadially F, Lalonde J, Wedge J. (1983) Ultrastructure of normal and torn menisci of the human knee joint. J. Anat. 136:773-91.
4. Radin EL. (1990) Factors influencing the progression of osteoarthritis. In: Articular Cartilage and Knee Joint Function. Ewing JW (ed.). Raven Press, New York, p. 301-9.
5. Hellio Le Gravetand M, Vigon E, Otterness IG, Hart DA. (2001) Early changes in lapine menisci during osteoarthritis development. Part II: molecular alterations. Osteoarthritis Cart. 9:65-72.
6. Hough AJ, Webber RJ. (1989) Pathology of the meniscus. Clin. Orthop. Rel. Res. 252:32-40.
7. Lange AK, Fiatarone Singh MA, Smith RM, Foroughi N, Baker MK, Shnier R, Vanwanseele B. (2007) Degenerative meniscus tears and mobility impairment in women with knee osteoarthritis. Osteoarthritis Cart. 15:701-8.
8. Berenbaum F. (2004) Signaling transduction: target in osteoarthritis. Curr. Opin. Rheumatol. 16:616-22.
9. Sweeney SE, Firestein GS. (2004) Signal transduction in rheumatoid arthritis. Curr. Opin. Rheumatol. 16:231-7.
10. Kumar S, Bohem J, Lee JC. (2003) p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory disease. Nat. Rev. Drug Discov. 2:717-26.
11. Johnson GL, Lapadat R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK and p38 protein kinases. Science 289:1911-2.
12. Nebreda AR, Porras A. (2000) p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25:257-60.
13. Pomerantz JL, Baltimore D. (2002) Two pathways to NF-?B. Mol. Cell. 10:693-701.
14. Tergaonkar V. (2006) NF-κB pathway: a good signaling paradigm for therapeutic target. Int. J. Biochem. Cell Biol. 38:1647-53.
15. Grilli M, Chiu JJ, Lenardo MJ. (1993) NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
16. Hayden MS, Ghosh S. (2004) Signaling to NF-κB. Genes Dev. 18:2195-224.
17. Barnes PJ, Karin M. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-71.
18. Smith WL, DeWitt DL, Garavito RM. (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145-82.
19. Kang Y-L, Mbonye UR, DeLong CL, Wada M, Smith WL. (2007) Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog. Lipids Res. 46:108-25.
20. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. (2006) Signaling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38:1654-61.
21. Harris E. (1990) Rheumatoid arthritis: pathophysiology and implications for therapy. N. Engl. J. Med. 322:1277.
22. Mesiha M, Zurakovski D, Soriano J, Nielson JH, Zarins B, Murray M. (2007) Pathologic characteristics of the torn human meniscus. Am. J. Sports Med. 35:103-12.
23. Papachristou DJ, Papachristou GI, Papaefthimiou OA, Agnantis NJ, Basdra EK, Papavassiliou AG. (2005) The MAPK-AP-1/Runx-2 signaling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF. Histopathology. 47:565-74.
24. Papadopoulou AK, Papachristou DJ, Chatzopoulos SA, Pirttiniemi P, Papavassiliou AG, Basdra EK. (2007) Load application induces changes in the expression of Sox-9 and FGFR-3 and VEGF in condylar chondrocytes. FEBS Lett. 581:2041-6.
25. Noble J, Hamblen DL. (1975) The pathology of degenerated meniscus lesion. J. Bone Joint Surg. Br. 57:180-6.
26. Loeser RF. (2006) Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum. 54:1357-60.
27. Hellio Le Gravetand M, Reno C, Hart DA. (1999) Gene expression in menisci from knees of skeletally mature female rabbits. J. Orthop. Res. 17:738-44.
28. Pennock AT, Robertson CM, Emmerson BC, Harwood FL, Amiel D. (2007) Role of apoptotic and matrix-degrading genes in articular cartilage and meniscus of mature and aged rabbits during development of osteoarthritis. Arthritis Rheum. 56:1529-36.
29. Takahashi M, Suzuki M, Kushida K, Hoshino H, Innue T. (1998) The effect of ageing and osteoarthritis on the mature and senescent cross-links of collagen in human meniscus. Arthroscopy. 14:366-72.
30. Chang L, Karin M. (2001) Mammalian MAP kinase signaling cascades. Nature. 410:37-40.
31. Cuardo A, Lafarga V, Cheung PCF, Donaldo I, Llanos S, Cohen P, Nebreda AR. (2007) A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J. 26:2115-26.
32. Tak PP, Firestein GS. (2001) NF-?B: a key role in inflammatory disease. J. Clin. Invest. 107:7-11.
33. Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Fink C, Guilak F. (2002) Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway. Osteoarthritis Cart. 10:792-8.
34. Hardy MM, Seibert KS, Manning PT, Currie MG, Woerner M, Edwards DE, Koki A, Tripp CS. (2002) Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum. 46:1789-1803.
35. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. (1992) Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:25934-8.